Avidity Biosciences Files 8-K Report
| Field | Detail |
|---|---|
| Company | Avidity Biosciences, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, financials
TL;DR
Avidity Biosciences filed an 8-K, mostly routine stuff, check exhibits for details.
AI Summary
On June 9, 2025, Avidity Biosciences, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events, with no specific material events or financial figures detailed in the provided text.
Why It Matters
This 8-K filing indicates routine corporate reporting by Avidity Biosciences, Inc., providing updates on financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no disclosed material events or significant financial changes, indicating low immediate risk.
Key Players & Entities
- Avidity Biosciences, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Avidity Biosciences, Inc.?
The filing is a Current Report on Form 8-K, primarily for Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Avidity Biosciences, Inc.
In which state was Avidity Biosciences, Inc. incorporated?
Avidity Biosciences, Inc. was incorporated in Delaware.
What is the principal executive office address for Avidity Biosciences, Inc.?
The principal executive office is located at 10578 Science Center Drive, Suite 125, San Diego, California 92121.
What is the Commission File Number for Avidity Biosciences, Inc.?
The Commission File Number for Avidity Biosciences, Inc. is 001-39321.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Avidity Biosciences, Inc..